IGM Biosciences, Inc.Pembelian
החברה עולה בעקבות דו"חות אבל המספרים הם לא המהות
חברת IGM Biosciences, Inc. מפרסמת דו"חות ומחיר המניה שלה (IGMS) מכפיל את עצמו - לא בגלל הדו"ח אלא בגלל הפרסום הנלווה לדו"ח
– Announced Global Collaboration Agreement with Sanofi for Oncology, Autoimmune and Inflammation Targets; IGM to Receive $150 Million Upfront Payment and potentially more than $6 Billion in Aggregate Development, Regulatory and Commercial Milestones –
– Announced Global Collaboration Agreement with Sanofi for Oncology, Autoimmune and Inflammation Targets; IGM to Receive $150 Million Upfront Payment and potentially more than $6 Billion in Aggregate Development, Regulatory and Commercial Milestones –
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.